| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 73.29B | 78.55B | 68.99B | 70.42B | 57.27B | 59.01B |
| Gross Profit | 64.55B | 70.32B | 64.33B | 66.56B | 54.03B | 54.03B |
| EBITDA | 19.08B | 22.06B | 20.16B | 19.28B | 16.51B | 15.51B |
| Net Income | 13.52B | 13.15B | 11.26B | 10.87B | 9.00B | 8.02B |
Balance Sheet | ||||||
| Total Assets | 5.47T | 5.47T | 5.40T | 5.33T | 5.49T | 5.32T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 161.49B | 230.92B | 484.39B | 790.92B | 739.97B |
| Total Debt | 76.45B | 76.45B | 70.92B | 133.58B | 415.30B | 711.02B |
| Total Liabilities | 5.20T | 5.21T | 5.13T | 5.07T | 5.24T | 5.07T |
| Stockholders Equity | 275.01B | 267.93B | 274.10B | 252.88B | 250.52B | 249.15B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 19.62B | 2.85B | -227.94B | 110.83B | 417.07B |
| Operating Cash Flow | 0.00 | 20.54B | 4.60B | -225.62B | 124.33B | 425.70B |
| Investing Cash Flow | 0.00 | -158.54B | -219.48B | -77.62B | -70.81B | -57.73B |
| Financing Cash Flow | 0.00 | 68.31B | 117.50B | -3.24B | -2.66B | -2.69B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥372.49B | 7.80 | ― | 1.95% | 19.69% | 50.61% | |
75 Outperform | ¥1.51T | 12.46 | 7.38% | 2.62% | 15.86% | 24.81% | |
71 Outperform | ¥262.22B | 14.45 | ― | 2.13% | 7.77% | 5.80% | |
70 Outperform | ¥240.57B | 8.55 | ― | 3.00% | 10.56% | 16.02% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | ¥128.14B | 9.42 | ― | 0.58% | 15.03% | 16.66% | |
59 Neutral | ¥264.74B | 10.68 | ― | 2.55% | -0.36% | 41.38% |